Biochemical recurrence following radical prostatectomy for intermediate-risk and high-risk prostate cancer is common. However, not all patients with recurrence will die from their disease. This comprehensive Review from a multidisciplinary group discusses the optimal evaluation and management of these patients to ensure balance between treatment-related morbidity and cancer control.
- Nicholas G. Zaorsky
- Jeremie Calais
- Amar U. Kishan
